Nonalcoholic Steatohepatitis (NASH) Latest Advances

Find the Latest Research About Nonalcoholic Steatohepatitis (NASH)

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5287 publications

Corrigendum to "Pharmaceutical optimization of chitosan tablets is associated with reduced circulating bile acids and fibrosis-related molecular signatures in non-alcoholic steatohepatitis rats" [Carbohydrate Polymers 383 (2026) 125333].

Corrigendum to "Pharmaceutical optimization of chitosan tablets is associated with reduced circulating bile acids and fibrosis-related molecular signatures in non-alcoholic steatohepatitis rats" [Carbohydrate Polymers 383 (2026) 125333].

Journal: Carbohydrate polymers

Published: June 02, 2026

Correction: Empagliflozin attenuates dexamethasone-induced non-alcoholic steatohepatitis by regulation of ferroptosis, inflammation and autophagy.

Correction: Empagliflozin attenuates dexamethasone-induced non-alcoholic steatohepatitis by regulation of ferroptosis, inflammation and autophagy.

Journal: Frontiers in pharmacology

Published: May 07, 2026

Corrigendum to "CISD2-mediated mitochondrial dysfunction and iron redistribution contributes to ferroptosis in arsenic-induced nonalcoholic steatohepatitis" [Ecotoxicol. Environ. Saf. 289:117694/EES-23-4255].

Corrigendum to "CISD2-mediated mitochondrial dysfunction and iron redistribution contributes to ferroptosis in arsenic-induced nonalcoholic steatohepatitis" [Ecotoxicol. Environ. Saf. 289:117694/EES-23-4255].

Journal: Ecotoxicology and environmental safety

Published: April 15, 2026

Editorial: Adaptive immune regulation of non-alcoholic steatohepatitis (NASH).

Editorial: Adaptive immune regulation of non-alcoholic steatohepatitis (NASH).

Journal: Frontiers in immunology

Published: April 02, 2026

Correction: Empagliflozin attenuates dexamethasone-induced non-alcoholic steatohepatitis by regulation of ferroptosis, inflammation and autophagy.

Correction: Empagliflozin attenuates dexamethasone-induced non-alcoholic steatohepatitis by regulation of ferroptosis, inflammation and autophagy.

Journal: Frontiers in pharmacology

Published: March 20, 2026

Effects of Zaozhu Yinchen Decoction on a Rat Model of Nonalcoholic Steatohepatitis via Regulation of Myeloid-Derived Suppressor Cells.

Effects of Zaozhu Yinchen Decoction on a Rat Model of Nonalcoholic Steatohepatitis via Regulation of Myeloid-Derived Suppressor Cells.

Journal: Hepatic medicine : evidence and research

Published: March 07, 2026

Correction to "Design, Synthesis, and Biological Evaluation of Chromone Derivatives as STAT1 Inhibitors for Treatment of Nonalcoholic Steatohepatitis".

Correction to "Design, Synthesis, and Biological Evaluation of Chromone Derivatives as STAT1 Inhibitors for Treatment of Nonalcoholic Steatohepatitis".

Journal: Journal of medicinal chemistry

Published: March 05, 2026

MRI multicomponent relaxometry for liver fibrosis, inflammation, and steatosis in nonalcoholic steatohepatitis: A prospective study.

MRI multicomponent relaxometry for liver fibrosis, inflammation, and steatosis in nonalcoholic steatohepatitis: A prospective study.

Journal: European journal of radiology

Published: March 04, 2026

Pharmaceutical optimization of chitosan tablets is associated with reduced circulating bile acids and fibrosis-related molecular signatures in non-alcoholic steatohepatitis rats.

Pharmaceutical optimization of chitosan tablets is associated with reduced circulating bile acids and fibrosis-related molecular signatures in non-alcoholic steatohepatitis rats.

Journal: Carbohydrate polymers

Published: January 30, 2026

Design, Synthesis, and Biological Evaluation of Chromone Derivatives as STAT1 Inhibitors for Treatment of Nonalcoholic Steatohepatitis.

Design, Synthesis, and Biological Evaluation of Chromone Derivatives as STAT1 Inhibitors for Treatment of Nonalcoholic Steatohepatitis.

Journal: Journal of medicinal chemistry

Published: January 27, 2026

Multivariate time-series forecasting of liver biomarkers from longitudinal lifestyle data for nonalcoholic steatohepatitis detection.

Multivariate time-series forecasting of liver biomarkers from longitudinal lifestyle data for nonalcoholic steatohepatitis detection.

Journal: JAMIA open

Published: January 16, 2026

MRI-derived visceral adipose tissue quantification enhances stratification of nonalcoholic steatohepatitis severity and fibrosis in obesity.

MRI-derived visceral adipose tissue quantification enhances stratification of nonalcoholic steatohepatitis severity and fibrosis in obesity.

Journal: Abdominal radiology (New York)

Published: January 07, 2026

Showing 1-12 of 5,287

Last Updated: 06/30/2026